Shan Y, Ding B, Ji F, Lin H, et al. T-cell receptor-like chimeric antigen receptor T cells targeting mesothelin: A first-in-human dose-escalation trial for platinum-resistant advanced ovarian cancer. Cancer 2026;132:e70279.
PMID: 41575866